Barcelona-based Ona Therapeutics, which is focused on treating metastatic cancer, has raised 30 million euros in Series A financing. The investors were Asabys Partners, Alta Life Sciences, Bpifrance – InnoBio 2, Fund+ and Ysios Capital.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: